156 related articles for article (PubMed ID: 32020849)
21. MiR-501-3p promotes osteosarcoma cell proliferation, migration and invasion by targeting BCL7A.
Dai J; Lu L; Kang L; Zhang J
Hum Cell; 2021 Mar; 34(2):624-633. PubMed ID: 33415690
[TBL] [Abstract][Full Text] [Related]
22. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
23. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-221 promotes cisplatin resistance in osteosarcoma cells by targeting PPP2R2A.
Yu WC; Chen HH; Qu YY; Xu CW; Yang C; Liu Y
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221814
[TBL] [Abstract][Full Text] [Related]
25. Restoration of microRNA-130b expression suppresses osteosarcoma cell malignant behavior
Wu Y; Sun W; Kong Y; Liu B; Zeng M; Wang W
Oncol Lett; 2018 Jul; 16(1):97-104. PubMed ID: 29928390
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance.
Ye G; Fu G; Cui S; Zhao S; Bernaudo S; Bai Y; Ding Y; Zhang Y; Yang BB; Peng C
J Cell Sci; 2011 Feb; 124(Pt 3):359-68. PubMed ID: 21224400
[TBL] [Abstract][Full Text] [Related]
27. Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4.
Chen B; Bao Y; Chen X; Yi J; Liu S; Fang Z; Zheng S; Chen J
Biomed Pharmacother; 2015 Oct; 75():1-7. PubMed ID: 26463624
[TBL] [Abstract][Full Text] [Related]
28. [Lethal effects of nanoliposome encapsulated cisplatin on Saos-2 cells and its distribution in nude mice bearing human].
Wang GW; Guo W; Tang XD; Peng CL; Zhao H
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):525-30. PubMed ID: 19829667
[TBL] [Abstract][Full Text] [Related]
29. miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22.
Li X; Jiang H; Xiao L; Wang S; Zheng J
Med Sci Monit; 2017 Feb; 23():1001-1008. PubMed ID: 28234890
[TBL] [Abstract][Full Text] [Related]
30. Quercetin Augments Cisplatin-Induced Apoptosis, DNA Damage Response, and MiR-22 Expression While It Prevents DNA Repair in Osteosarcoma Cells.
Malakoti F; Majidinia M; Ahmadi Y; Yousefi B; Shanebandi D
Drug Res (Stuttg); 2022 Sep; 72(7):378-384. PubMed ID: 35724673
[TBL] [Abstract][Full Text] [Related]
31. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
32. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.
Xu JQ; Zhang WB; Wan R; Yang YQ
Tumour Biol; 2014 Oct; 35(10):9847-53. PubMed ID: 24989927
[TBL] [Abstract][Full Text] [Related]
35. MiR-134, Mediated by IRF1, Suppresses Tumorigenesis and Progression by Targeting VEGFA and MYCN in Osteosarcoma.
Ma Z; Li K; Chen P; Pan Q; Li X; Zhao G
Anticancer Agents Med Chem; 2020; 20(10):1197-1208. PubMed ID: 32238141
[TBL] [Abstract][Full Text] [Related]
36. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
[TBL] [Abstract][Full Text] [Related]
37. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
[No Abstract] [Full Text] [Related]
38. MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A.
Luo W; He H; Xiao W; Liu Q; Deng Z; Lu Y; Wang Q; Zheng Q; Li Y
Oncotarget; 2016 Aug; 7(34):54733-54743. PubMed ID: 27458156
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-340-5p modulates cisplatin resistance by targeting LPAATβ in osteosarcoma.
Song L; Duan P; Gan Y; Li P; Zhao C; Xu J; Zhang Z; Zhou Q
Braz J Med Biol Res; 2017 Apr; 50(5):e6359. PubMed ID: 28443990
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA SERTAD2-3 Inhibits Osteosarcoma Proliferation and Migration by Competitively Binding miR-29c.
Zhang Z; Liu J; Wu Y; Zhao X; Hao Y; Wang X; Xue C; Wang Y; Zhang R; Zhang X
Genet Test Mol Biomarkers; 2020 Feb; 24(2):67-72. PubMed ID: 31999493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
